Asia Vital Components 과거 수익 실적
과거 기준 확인 6/6
Asia Vital Components은 연평균 35.4%의 비율로 수입이 증가해 온 반면, Tech 산업은 수입이 증가했으며, 연간 11.7%였습니다. 매출은 연평균 12.9%의 비율로 증가했습니다. Asia Vital Components의 자기자본이익률은 26.9%이고 순이익률은 11.1%입니다.
주요 정보
35.4%
수익 성장률
33.6%
EPS 성장률
| Tech 산업 성장 | 14.0% |
| 매출 성장률 | 12.9% |
| 자기자본 수익률 | 26.9% |
| 순이익 | 11.1% |
| 최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17
A Look At The Fair Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Nov 03Asia Vital Components Co., Ltd. (TWSE:3017) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Oct 18Is Now The Time To Put Asia Vital Components (TWSE:3017) On Your Watchlist?
Oct 14Is Asia Vital Components (TWSE:3017) A Risky Investment?
Sep 28Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results
Aug 13Asia Vital Components Co., Ltd.'s (TWSE:3017) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Aug 06Is Asia Vital Components Co., Ltd. (TWSE:3017) Worth NT$634 Based On Its Intrinsic Value?
Jul 22Asia Vital Components (TWSE:3017) Is Investing Its Capital With Increasing Efficiency
Jul 04Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce
May 29We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease
May 21Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?
Apr 17A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Apr 03Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)
Mar 21Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher
Feb 26Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?
Apr 23Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?
Apr 08Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Mar 21Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?
Feb 16Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01
Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?
Jan 17수익 및 비용 분석
수익 및 비용 분석
Asia Vital Components 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Sep 24 | 67,577 | 7,506 | 1,775 | 3,631 |
| 30 Jun 24 | 64,281 | 6,608 | 1,811 | 3,534 |
| 31 Mar 24 | 62,669 | 5,862 | 1,943 | 3,478 |
| 31 Dec 23 | 59,194 | 5,305 | 1,838 | 3,129 |
| 30 Sep 23 | 57,251 | 4,715 | 1,844 | 3,002 |
| 30 Jun 23 | 56,365 | 4,528 | 1,823 | 2,977 |
| 31 Mar 23 | 55,258 | 4,423 | 1,687 | 2,907 |
| 31 Dec 22 | 56,017 | 4,162 | 1,659 | 2,885 |
| 30 Sep 22 | 53,452 | 3,792 | 1,526 | 2,778 |
| 30 Jun 22 | 50,342 | 3,407 | 1,386 | 2,580 |
| 31 Mar 22 | 49,327 | 3,106 | 1,261 | 2,420 |
| 31 Dec 21 | 47,333 | 2,901 | 1,194 | 2,365 |
| 30 Sep 21 | 45,646 | 2,704 | 1,183 | 2,314 |
| 30 Jun 21 | 43,922 | 2,490 | 1,149 | 2,258 |
| 31 Mar 21 | 42,778 | 2,262 | 1,050 | 2,079 |
| 31 Dec 20 | 39,666 | 1,916 | 1,020 | 1,929 |
| 30 Sep 20 | 39,361 | 1,690 | 1,036 | 1,987 |
| 30 Jun 20 | 39,228 | 1,308 | 1,043 | 1,920 |
| 31 Mar 20 | 37,107 | 972 | 1,106 | 1,934 |
| 31 Dec 19 | 36,534 | 958 | 1,117 | 1,938 |
| 30 Sep 19 | 34,258 | 871 | 1,123 | 1,859 |
| 30 Jun 19 | 31,962 | 800 | 1,138 | 1,773 |
| 31 Mar 19 | 29,482 | 747 | 1,148 | 1,669 |
| 31 Dec 18 | 29,067 | 711 | 1,139 | 1,589 |
| 30 Sep 18 | 28,673 | 717 | 1,088 | 1,510 |
| 30 Jun 18 | 27,873 | 776 | 983 | 1,380 |
| 31 Mar 18 | 27,178 | 811 | 905 | 1,282 |
| 31 Dec 17 | 27,109 | 887 | 931 | 1,246 |
| 30 Sep 17 | 26,750 | 930 | 944 | 1,230 |
| 30 Jun 17 | 26,496 | 898 | 997 | 1,269 |
| 31 Mar 17 | 26,528 | 869 | 1,027 | 1,271 |
| 31 Dec 16 | 26,504 | 860 | 1,008 | 1,250 |
| 30 Sep 16 | 26,040 | 826 | 967 | 1,142 |
| 30 Jun 16 | 26,312 | 829 | 1,000 | 1,127 |
| 31 Mar 16 | 26,194 | 797 | 1,000 | 1,147 |
| 31 Dec 15 | 25,675 | 741 | 980 | 1,179 |
| 30 Sep 15 | 25,023 | 681 | 1,011 | 1,283 |
| 30 Jun 15 | 24,317 | 822 | 1,016 | 1,310 |
| 31 Mar 15 | 24,336 | 820 | 1,046 | 1,332 |
| 31 Dec 14 | 24,047 | 729 | 1,064 | 1,314 |
| 30 Sep 14 | 23,739 | 640 | 1,020 | 1,226 |
| 30 Jun 14 | 22,767 | 355 | 980 | 1,156 |
| 31 Mar 14 | 21,397 | 282 | 982 | 1,112 |
| 31 Dec 13 | 19,990 | 246 | 979 | 1,070 |
양질의 수익: 3017 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: 3017 의 현재 순이익 이익률 (11.1%) 작년보다 높습니다 (8.2%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: 3017 의 수익은 지난 5년 동안 매년 35.4% 씩 크게 증가했습니다.
성장 가속화: 지난 1년간 3017 의 수익 증가율( 59.2% )은 연간 평균( 35.4% 초과합니다. ).
수익 대 산업: 지난 1년간 3017 수익 증가율( 59.2% )은 Tech 업계 10% 초과했습니다.
자기자본 수익률
높은 ROE: 3017 의 자본 수익률( 26.9% )은 높음으로 간주됩니다.